InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Yates Robert Clifton, Director. Director active across 1 companies, notably Ortho Clinical Diagnostics Holdings plc. Aggregated, 10 filings have been logged. The latest transaction was disclosed on 31 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
323,880 shares
Ordinary Shares, $0.00001 par value
SEC:0000899243-22-020380:0·
€3,606214 shares@ €16.85281.4% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-22-022307:0·
€3,974214 shares@ €18.56953.0% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-22-001680·
€3,974214 shares@ €18.56951.5% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-22-001680:0·
€4,842277 shares@ €17.4813.7% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-058933·
€4,842277 shares@ €17.4811.8% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-058933:0·
€121,96523,062 shares@ €5.288693.3% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-049758·
€121,96523,062 shares@ €5.288646.0% of flow
Ordinary Shares, $0.00001 par value
SEC:0001209191-21-049758:0·
05,200 shares0
Ordinary Shares
SEC:0001209191-21-030374·
05,200 shares0
Ordinary Shares
SEC:0001209191-21-030374:0·
10 of 10 declarations
About Yates Robert Clifton
Robert Clifton Yates is a Director at Ortho Clinical Diagnostics Holdings plc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the clinical diagnostics sector is valuable for guiding growth and innovation initiatives.
